Brookfield Asset Management Ltd. is reportedly preparing to abandon its bid for Grifols SA due to ongoing disagreements over the valuation of the Spanish pharmaceutical company.

After months of negotiations that began in July, Brookfield has decided to walk away after failing to reach a consensus with Grifols' board regarding the acquisition price.

Despite having secured financing for the deal and formulating a turnaround strategy for Grifols, the inability to agree on terms has led to this decision.

Sources familiar with the situation indicate that Brookfield's exit marks a significant shift in the potential acquisition landscape for Grifols.